Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner

Journal of Lipid Research

Volumn 47, Issue 7, 2006, Pages 1542-1550

  Abe Dohmae, Sumiko ^a   Kato, Koichi H ^b   Kumon, Yoshitaka ^c   Hu, Wei ^a   Ishigami, Hideaki ^a   Iwamoto, Noriyuki ^a   Okazaki, Mitsuyo ^d   Wu, Chen Ai ^a   Tsujita, Maki ^a   Ueda, Kazumitsu ^e   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Apolipoprotein; ATP binding cassette transporter A1; ATP binding cassette transporter A7; Cholesterol

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BUCLADESINE; CARRIER PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPID; PROTEIN ABC TRANSPORTER A7; RETINOID X RECEPTOR; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CHRONIC INFLAMMATION; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; UPREGULATION;

EID: 33746077127     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600145-JLR200     Document Type: Article

References (53)

1. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
2. Kushner, I. 1982. The phenomenon of the acute phase response. Ann. N. Y. Acad. Sci. 389: 39-48.
3. -/- mice. J. Lipid Res. 40: 1090-1103.
4. Turnell, W., R. Sarra, I. D. Glover, J. O. Baum, D. Caspi, M. L. Baltz, and M. B. Pepys. 1986. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 3: 387-407.
5. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
6. Hari-Dass, R., C. Shah, D. J. Meyer, and J. G. Raynes. 2005. Serum amyloid A protein binds to outer membrane protein A of Gram-negative bacteria. J. Biol. Chem. 280: 18562-18567.
7. Patel, H., R. Fellowes, S. Coade, and P. Woo. 1998. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48: 410-418.
8. Vishnyakova, T. G., A. V. Bocharov, I. N. Baranova, Z. Chen, A. T. Remaley, G. Csako, T. L. Eggerman, and A. P. Patterson. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J. Biol. Chem. 278: 22771-22780.
9. Bocharov, A. V., I. N. Baranova, T. G. Vishnyakova, A. T. Remaley, G. Csako, F. Thomas, A. P. Patterson, and T. L. Eggerman. 2004. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical- containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J. Biol. Chem. 279: 36072-36082.
10. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, et al. 2005. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280: 8031-8040.
11. Levin, M., E. C. Franklin, B. Frangione, and M. Pras. 1972. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J. Clin. Invest. 51: 2773-2776.
12. Levin, M., M. Pras, and E. C. Franklin. 1973. Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J. Exp. Med. 138: 373-380.
13. Cai, L., M. C. de Beer, F. C. de Beer, and D. R. van der Westhuyzen. 2005. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 280: 2954-2961.
14. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90: 12040-12044.
15. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64: 1516-1524.
16. Cavaillon, J. M., C. Fitting, N. Haeffner-Cavaillon, S. J. Kirsch, and H. S. Warren. 1990. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58: 2375-2382.
17. Salazar, A., J. Mana, C. Fiol, I. Hurtado, J. M. Argimon, R. Pujol, and X. Pinto. 2000. Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis. 152: 497-502.
18. Yokoyama, S. 2000. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim. Biophys. Acta. 1529: 231-244.
19. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96: 78-87.
20. Remaley, A. T., U. K. Schumacher, J. A. Stonik, B. D. Farsi, H. B. Nazih, and H. B. Brewer, Jr. 1997. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17: 1813-1821.
21. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
22. Brooks-Wilson, A., M. Marcil, S. M. Clee, L-H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. F. Molhuizen, et al. 1999. Mutations in ABC 1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
23. Marcil, M., A. Brooks-Wilson, S. M. Clee, K. Roomp, L. H. Zhang, L. Yu, J. A. Collins, M. van Dam, H. O. Molhuizen, O. Loubster, et al. 1999. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354: 1341-1346.
24. Remaley, A. T., S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K. M. Peterson, C. Koch, I. Arnould, C. Prades, et al. 1999. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA. 96: 12685-12690.
25. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J-C. Piette, J-F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP binding-cassette transporter 1. Nat. Genet. 22: 352-355.
26. Wang, N., D. Lan, M. Gerbod-Giannone, P. Linsel-Nitschke, A. W. Jehle, W. Chen, L. O. Martinez, and A. R. Tall. 2003. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem. 278: 42906-42912.
27. Abe-Dohmae, S., Y. Ikeda, M. Matsuo, M. Hayashi, K. Okuhira, K. Ueda, and S. Yokoyama. 2004. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 279: 604-611.
28. Stonik, J. A., A. T. Remaley, S. J. Demosky, E. B. Neufeld, A. Bocharov, and H. B. Brewer. 2004. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem. Biophys. Res. Commun. 321: 936-941.
29. Yokoyama, S., S. Tajima, and A. Yamamoto. 1982. The process of dissolving apolipoprotein A-I in an aqueous buffer. J. Biochem. (Tokyo). 91: 1267-1272.
30. Abe-Dohmae, S., S. Suzuki, Y. Wada, H. Aburatani, D. E. Vance, and S. Yokoyama. 2000. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry. 39: 11092-11099.
31. Arakawa, R., S. Abe-Dohmae, M. Asai, J. Ito, and S. Yokoyama. 2000. Involvement of caveolin-1 in cholesterol-enrichment of HDL during its assembly by apolipoprotein and THP-1 cells. J. Lipid Res. 41: 1952-1962.
32. Kojima, K., S. Abe-Dohmae, R. Arakawa, I. Murakami, K. Suzumori, and S. Yokoyama. 2001. Progesterone inhibits apolipoprotein-mediated cellular lipid release: a putative mechanism for the decrease of HDL. Biochim. Biophys. Acta. 1532: 173-184.
33. Arakawa, R., and S. Yokoyama. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter A1by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277: 22426-22429.
34. Ikeda, Y., S. Abe-Dohmae, Y. Munehira, R. Aoki, S. Kawamoto, A. Furuya, K. Shitara, T. Amachi, N. Kioka, M. Matsuo, et al. 2003. Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem. Biophys. Res. Commun. 311: 313-318.
35. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
36. Okazaki, M., S. Usui, and S. Hosaki. 2000. Analysis of plasma lipoproteins by gel permeation chromatography. In Handbook of Lipoprotein Testing. N. Rifai, G. R. Warnick, and M. H. Dominiczak, editors. AACC Press, Washington, DC. 647-669.
37. Usui, S., Y. Hara, S. Hosaki, and M. Okazaki. 2002. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res. 43: 805-814.
38. Tsujita, M., C. A. Wu, S. Abe-Dohmae, S. Usui, M. Okazaki, and S. Yokoyama. 2005. On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. J. Lipid Res. 46: 154-162.
39. Hayashi, M., S. Abe-Dohmae, M. Okazaki, K. Ueda, and S. Yokoyama. 2005. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J. Lipid Res. 46: 1703-1711.
40. Ito, J., Y. Nagayasu, K. Kato, R. Sato, and S. Yokoyama. 2002. Apolipoprotein A-I induces translocation of cholesterol, phospholipid and caveolin-1 to cytosol in rat astrocytes. J. Biol. Chem. 277: 7929-7935.
41. Okuhira, K., M. Tsujita, Y. Yamauchi, S. Abe-Dohmae, K. Kato, T. Handa, and S. Yokoyama. 2004. Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J. Lipid Res. 45: 645-652.
42. Yamauchi, Y., S. Abe-Dohmae, and S. Yokoyama. 2002. Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release. Biochim. Biophys. Acta. 1585: 1-10.
43. Yamauchi, Y., M. Hayashi, S. Abe-Dohmae, and S. Yokoyama. 2003. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J. Biol. Chem. 278: 47890-47897.
44. Arakawa, R., M. Hayashi, A. T. Remaley, B. H. Brewer, Y. Yamauchi, and S. Yokoyama. 2004. Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J. Biol. Chem. 279: 6217-6220.
45. Hara, H., H. Hara, A. Komaba, and S. Yokoyama. 1992. α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 27: 302-304.
46. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
47. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
48. Remaley, A. T., F. Thomas, J. A. Stonik, S. J. Demosky, S. E. Bark, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, A. P. Patterson, T. L. Eggerman, et al. 2003. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J. Lipid Res. 44: 828-836.
49. Miida, T., C. J. Fielding, and P. E. Fielding. 1990. Mechanism of transfer of LDL-derived free cholesterol to HDL subfraction in human plasma. Biochemistry. 29: 10469-10474.
50. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
51. Yan, S. D., H. Zhu, A. Zhu, A. Golabek, H. Du, A. Roher, J. Yu, C. Soto, A. M. Schmidt, D. Stern, et al. 2000. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6: 643-651.
52. Walder, K., L. Kantham, J. S. McMillan, J. Trevaskis, L. Kerr, A. De Silva, T. Sunderland, N. Godde, Y. Gao, N. Bishara, et al. 2002. Tanis: a link between type 2 diabetes and inflammation? Diabetes. 51: 1859-1866.
53. Kryukov, G. V., S. Castellano, S. V. Novoselov, A. V. Lobanov, O. Zehtab, R. Guigo, and V. N. Gladyshev. 2003. Characterization of mammalian selenoproteomes. Science. 300: 1439-1443.